Thromb Haemost 1989; 61(01): 154
DOI: 10.1055/s-0038-1646550
Letter to the Editor
Schattauer GmbH Stuttgart

Elevated Plasma Concentrations of Fibrinogen May Cause an Overestimation of Functional Plasminogen

Jørgen Gram
The Section of Coagulation and Fibrinolysis, Department of Clinical Chemistry, Ribe County Hospital in Esbjerg, and Section of Thrombosis Research, South Jutland University Centre, Esbjerg, Denmark
,
Steffen Munkvad
The Section of Coagulation and Fibrinolysis, Department of Clinical Chemistry, Ribe County Hospital in Esbjerg, and Section of Thrombosis Research, South Jutland University Centre, Esbjerg, Denmark
,
Jørgen Jespersen
The Section of Coagulation and Fibrinolysis, Department of Clinical Chemistry, Ribe County Hospital in Esbjerg, and Section of Thrombosis Research, South Jutland University Centre, Esbjerg, Denmark
› Author Affiliations
Further Information

Publication History

Received 28 August 1988

Accepted after revision 11 October 1988

Publication Date:
24 July 2018 (online)

 
  • References

  • 1 Soria J, Soria C, Bertrand O, Dunn F, Samama M, Bachmann F. The amidolytic activity of the SK-plasminogen complex is enhanced by a potentiator which is generated in the presence of vascular plasminogen activator - role of fibrin degradation products. Thromb Haemostas 1982; 47: 193-196
  • 2 Gram J, Jespersen J. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples. Thromb Haemostas 1985; 53: 255-259
  • 3 Castellino FJ, Strickland DK, Morris JP, Smith J, Chibber B. Enhancement of the streptokinase-induced activation of human plasminogen by human fibrinogen and human fibrinogen fragment D1 . Ann NY Acad Sci 1983; 408: 595-601
  • 4 Camiolo SM, Markus G, Evers JL, Hobika GH. Augmentation of streptokinase activator activity by fibrinogen or fibrin. Thromb Res 1980; 17: 697-706
  • 5 Takada A, Takada Y. Potentiation of the activation of glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products. Thromb Res 1982; 25: 229-235